BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced that Maria Maccecchini, Ph.D., Founder, President, and CEO, will be participating in the Systems Biology of Alzheimer’s Disease Panel at the Alzheimer’s Association International Conference.
The panel will focus on the need and underpinning rationale for advancing novel therapeutic approaches for Alzheimer’s disease. The four companies will present their novel approaches as well as outlook on developments impacting clinical trials and patients.
This panel is aligned with AAIC’s “Part the Cloud” program, which strives to promote and fund novel research with the highest probability of slowing, stopping or ultimately curing Alzheimer’s disease.
The panel is scheduled to take place on August 4th, 2022, at 8-9:15 AM Pacific Time / 11 AM – 12:15 PM Eastern Time. Interested parties may access a live panel discussion through the AAIC 2022 conference site and archived webcast of the presentation on the Company’s investor relations website at: www.annovisbio.com.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.